Easom Eric
AN2 Therapeutics, Inc. · Chief Executive Officer
Easom Eric is listed in public filings as director, officer: Chief Executive Officer. This Easom Eric insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include AN2 Therapeutics, Inc. (ANTX). Investors use Easom Eric's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0225k shares | OtherMar 19, 2026 | $3.9M225k shares | $17.28 | -- | |
| $0267.7k shares | OtherMar 19, 2026 | $3.2M267.7k shares | $11.99 | -- | |
| $0250k shares | OtherMar 19, 2026 | $1.6M250k shares | $6.60 | -- | |
| $1.0M267.7k shares | Grant / ExerciseMar 19, 2026 | $1.0M267.7k shares | $3.91 | -- | |
| $977k250k shares | Grant / ExerciseMar 19, 2026 | $977.5K250k shares | $3.91 | -- | |
| $880k225k shares | Grant / ExerciseMar 19, 2026 | $879.8K225k shares | $3.91 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $233k224.5k shares | Grant / ExerciseFeb 20, 2026 | $233.5K224.5k shares | $1.04 | -- | |
| --368.6k shares | Grant / ExerciseFeb 20, 2026 | Disclosure amount unavailable112.3k shares | -- | -- | |
| $273k256.4k shares | BuyJun 2, 2025 | $10.7K10k shares | $1.07 | -- | |
| $328k290.5k shares | Grant / ExerciseFeb 26, 2025 | $328.3K290.5k shares | $1.13 | -- | |
| --246.4k shares | Grant / ExerciseFeb 26, 2025 | Disclosure amount unavailable145.3k shares | -- | -- | |
| $1.1M1.1M shares | BuyNov 18, 2024 | $50.0K50k shares | $0.9994 | -- |